معرفی
Marie Larsson is a Professor and Head of the Division of Molecular Medicine and Virology (MMV) at Linköping University, Sweden. She leads research in immunovirology, focusing on HIV’s impact on dendritic cells (DCs) and T cells, as well as vaccine development for cancer and viral infections. Her work explores HIV’s immunomodulatory effects, including DC hijacking and impaired T cell activation, and investigates cancer-associated inflammation. She has secured significant grants, including SEK 64 million from the Swedish Research Council, and contributed to SARS-CoV-2 research during the pandemic, studying long-term immune impacts and developing diagnostic tools.
- Education: Not explicitly stated in provided texts.
- Affiliations: Division of Molecular Medicine and Virology, Department of Biomedical and Clinical Sciences (BKV), Mucosa Infection and Inflammation Center (MIIC).
Her research integrates molecular biology and translational medicine, with a focus on:
- Elucidating HIV’s mechanisms of immune evasion and DC dysfunction.
- Developing adjuvants and vaccines targeting cancer and viral pathogens.
- Understanding chronic inflammation’s role in immune dysregulation (e.g., tuberculosis, lupus).
Recent work highlights:
- Analysis of long-term immune perturbations post-COVID-19, including persistent T cell deficits and monocyte dysfunction.
- Studies on CRP’s dual roles in autoimmune diseases like SLE.
- Global surveillance of viral variants (e.g., mpox, SARS-CoV-2 omicron).
Grants & Leadership: Received major funding for medical research and oversees collaborative projects at MIIC. Her work bridges basic science and clinical applications, emphasizing translational outcomes.
Labs/Teams: Leads the Division of Molecular Medicine and Virology, collaborating with interdisciplinary teams on HIV, SARS-CoV-2, and other infectious diseases.
